ReviewNuclear medicine and molecular imaging2022

Current Status of PSMA-Targeted Radioligand Therapy in the Era of Radiopharmaceutical Therapy Acquiring Marketing Authorization.

So Won Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.